Éruptions psoriasiformes sous anti-TNFαSENESCHAL, Julien.La Revue du praticien. Médecine générale. 2014, Num 917, pp 206-207, issn 0989-2737, 2 p.Article

Les nouveaux anti-TNFαWENDLING, D.La Lettre du rhumatologue. 2009, Num 356, pp 14-15, issn 0761-5027, 2 p., SUPArticle

Quelles sont les nouvelles des anti-TNF dans le traitement de la PR ?DEVAUCHELLE-PENSEC, Valérie.La Lettre du rhumatologue. 2012, Num 379-80, pp 3-11, issn 0761-5027, 9 p., SUP1Article

Adverse Cutaneous Reactions Induced by TNF-α Antagonist TherapyBORRAS-BLASCO, Joaquin; NAVARRO-RUIZ, Andrés; BORRAS, Consuelo et al.Southern medical journal (Birmingham, Ala. Print). 2009, Vol 102, Num 11, pp 1133-1140, issn 0038-4348, 8 p.Article

Les anti-TNF en 2009 Compte-rendu du congrès de la SFRGAUJOUX-VIALA, Cécile; LEQUERRE, Thierry.La Lettre du rhumatologue. 2009, Num JUIN, pp 2-11, issn 0761-5027, 10 p., NS-INFOS-CONGRESArticle

ACNEIFORM ERUPTION FOLLOWING ANTI-TNF-ALPHA TREATMENT : A REPORT OF THREE CASESSUN, Grace; WASKO, Carina A; HSU, Sylvia et al.Journal of drugs in dermatology. 2008, Vol 7, Num 1, pp 69-71, issn 1545-9616, 3 p.Article

TNF-α antagonists beyond approved indications: stories of success and prospects for the futureKARAMPETSOU, M. P; LIOSSIS, S.-N. C; SFIKAKIS, P. P et al.QJM (Oxford. 1994. Print). 2010, Vol 103, Num 12, pp 917-928, issn 1460-2725, 12 p.Article

Is it safe to readminister tumor necrosis factor a antagonists following tuberculosis flare?ASLANIDIS, Spyros; PYRPASOPOULOU, Athina; DOUMA, Stella et al.Arthritis and rheumatism. 2008, Vol 58, Num 1, pp 327-328, issn 0004-3591, 2 p.Article

Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNFα single-chain Fv antibody (ESBA105) designed for local therapeutic useURECH, D. M; FEIGE, U; EWERT, S et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 2, pp 443-449, issn 0003-4967, 7 p.Article

Avantages et inconvénients des IGRA: Faut-il remplacer l'IDR ? : DEPISTAGE DE LA TUBERCULOSE: Que penser des nouveaux testsCABANTOUS, Laurence.Rhumatos. 2011, Vol 8, Num 72, pp 350-352, issn 1771-0081, 3 p.Article

Trouble With Tumor Necrosis Factor α Inhibitors, Not Just Tuberculosis : DRUG SAFETY IN THE RHEUMATIC DISEASESRACUNICA, Tina; CASSIDY, Dermot; CICUTTINI, Flavia et al.Arthritis care and research. 2010, Vol 62, Num 6, pp 770-774, issn 0893-7524, 5 p.Article

Thalidomide-induced severe hepatotoxicityDABAK, Vrushali; KURIAKOSE, Philip.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 4, pp 583-585, issn 0344-5704, 3 p.Article

Acute psychosis in three patients receiving anti-tumour necrosis factor-a therapyMCGREGOR, L; SAUNDERS, S. A; HUNTER, J. A et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 8, pp 1254-1255, issn 1462-0324, 2 p.Article

Comprendre les anti-TNF-α en 10 questions : Les biothérapies en rhumatologieBENBOUAZZA, K; HAJJAJ-HASSOUNI, N.Espérance médicale. 2008, Vol 15, Num 149, pp 286-290, 5 p.Article

Effets paradoxaux des agents anti-TNFαWENDLING, D.La Lettre du rhumatologue. 2007, Num 336, pp 11-12, issn 0761-5027, 2 p., SUPArticle

Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitorsEXARCHOU, S. A; VOULGARI, P. V; MARKATSELI, T. E et al.Scandinavian journal of rheumatology. 2009, Vol 38, Num 5, pp 328-331, issn 0300-9742, 4 p.Article

Effets paradoxaux des biomédicaments anti-TNFα = Paradoxical effects of anti-TNF-α biodrugsWENDLING, D; BRINSTER, A; SONDAG, M et al.La Lettre du rhumatologue. 2014, Num 402-03, pp 28-31, issn 0761-5027, 4 p.Article

Pityriasis rubra pilaris types 1 and 2: different responses to treatment with TNF-alpha antagonistsVUJIC, Igor; RICHTER, Leo; BARTSCH, Katrin et al.EJD. European journal of dermatology. 2013, Vol 23, Num 6, pp 895-896, issn 1167-1122, 2 p.Article

Efficacité des anti-TNF chez les patients atteints de spondyloarthropathie en l'absence de signes à l'imagerieBISSON-VAIVRE, Aurélia; ALCAIX, Didier; ZARNITSKY, Charles et al.Revue du rhumatisme (Ed. française). 2013, Vol 80, Num 3, pp 250-256, issn 1169-8330, 7 p.Article

ThalidomidePROMMER, Eric E; TWYCROSS, Robert; MIHALYO, Mary et al.Journal of pain and symptom management. 2011, Vol 41, Num 1, pp 140-145, issn 0885-3924, 6 p.Article

Anti-TNFα therapy—killing two birds with one stone?ARIF, Sefina; COX, Patricia; AFZALI, Behdad et al.Lancet (British edition). 2010, Vol 375, Num 9733, issn 0140-6736, p. 2278Article

Immunogénicité des anti-TNFαSARAUX, A.La Lettre du rhumatologue. 2007, Num 336, pp 3-4, issn 0761-5027, 2 p., SUPArticle

Bacteremia in patients receiving TNF-alpha antagonists — A prospective multicenter studyLOULERGUE, Pierre; TUBACH, Florence; LORTHOLARY, Olivier et al.The Journal of infection. 2013, Vol 67, Num 6, pp 524-528, issn 0163-4453, 5 p.Article

Pseudolymphome cutané avec deux anti-TNFα: effet de classe ? = Cutaneous pseudolymphoma with two types of anti-TNFα: A class effect?SCHMUTZ, J.-L; TRECHOT, P.Annales de dermatologie et de vénéréologie. 2012, Vol 139, Num 10, pp 695-696, issn 0151-9638, 2 p.Article

Pourquoi a-t-on développé les IGRA ?: Et pourquoi les utiliser en rhumatologie ? : DEPISTAGE DE LA TUBERCULOSE: Que penser des nouveaux testsCABANTOUS, Laurence.Rhumatos. 2011, Vol 8, Num 72, pp 347-349, issn 1771-0081, 3 p.Article